Medcom Tech SA
MAD:MED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medcom Tech SA
MAD:MED
|
ES |
Balance Sheet
Balance Sheet Decomposition
Medcom Tech SA
Medcom Tech SA
Balance Sheet
Medcom Tech SA
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
|
| Cash Equivalents |
1
|
1
|
1
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
|
| Short-Term Investments |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
12
|
11
|
11
|
12
|
10
|
10
|
8
|
9
|
11
|
11
|
|
| Accounts Receivables |
10
|
9
|
10
|
10
|
9
|
9
|
8
|
9
|
11
|
11
|
|
| Other Receivables |
2
|
2
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
9
|
11
|
15
|
15
|
14
|
6
|
6
|
6
|
6
|
7
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
23
|
23
|
27
|
28
|
25
|
17
|
16
|
17
|
19
|
19
|
|
| PP&E Net |
3
|
3
|
5
|
5
|
5
|
2
|
2
|
2
|
4
|
4
|
|
| PP&E Gross |
3
|
3
|
5
|
0
|
0
|
0
|
2
|
2
|
4
|
4
|
|
| Accumulated Depreciation |
3
|
4
|
5
|
0
|
0
|
0
|
4
|
5
|
4
|
5
|
|
| Intangible Assets |
0
|
0
|
3
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
0
|
0
|
0
|
2
|
5
|
5
|
4
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
28
N/A
|
31
+9%
|
36
+17%
|
37
+3%
|
33
-12%
|
23
-29%
|
23
-3%
|
25
+9%
|
27
+12%
|
28
+0%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
4
|
4
|
7
|
10
|
9
|
10
|
7
|
8
|
10
|
9
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| Short-Term Debt |
1
|
1
|
2
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4
|
6
|
10
|
7
|
4
|
0
|
2
|
2
|
4
|
3
|
|
| Other Current Liabilities |
1
|
1
|
1
|
3
|
2
|
2
|
1
|
1
|
2
|
2
|
|
| Total Current Liabilities |
11
|
12
|
21
|
21
|
19
|
15
|
10
|
11
|
15
|
14
|
|
| Long-Term Debt |
2
|
3
|
5
|
10
|
7
|
7
|
6
|
9
|
9
|
13
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
1
|
2
|
3
|
3
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
13
N/A
|
15
+20%
|
25
+62%
|
29
+17%
|
23
-20%
|
20
-16%
|
17
-15%
|
20
+23%
|
25
+21%
|
27
+7%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
4
|
0
|
4
|
6
|
15
|
14
|
16
|
3
|
1
|
|
| Additional Paid In Capital |
12
|
12
|
12
|
12
|
16
|
20
|
21
|
21
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
16
N/A
|
15
0%
|
11
-28%
|
8
-28%
|
9
+18%
|
4
-61%
|
6
+60%
|
4
-32%
|
3
-32%
|
1
-63%
|
|
| Total Liabilities & Equity |
28
N/A
|
31
+9%
|
36
+17%
|
37
+3%
|
33
-12%
|
23
-29%
|
23
-3%
|
25
+9%
|
27
+12%
|
28
+0%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
10
|
10
|
10
|
10
|
11
|
13
|
13
|
13
|
13
|
13
|
|